A novel Staphylococcus aureus vaccine: Iron surface determinant B induces rapid antibody responses in rhesus macaques and specific increased survival in a murine S. aureus sepsis model

Infection and Immunity

Volumn 74, Issue 4, 2006, Pages 2215-2223

  Kuklin, Nelly A ^a   Clark, Desmond J ^a   Secore, Susan ^a   Cook, James ^a   Cope, Leslie D ^a   McNeely, Tessie ^a   Noble, Liliane ^a   Brown, Martha J ^a   Zorman, Julie K ^a   Wang, Xin Min ^a   Pancari, Gregory ^a   Fan, Hongxia ^a   Isett, Kevin ^a   Burgess, Bruce ^a   Bryan, Janine ^a   Brownlow, Michelle ^a   George, Hugh ^a   Meinz, Maria ^a   Liddell, Mary E ^a   Kelly, Rosemarie ^a   Schultz, Loren ^a   Montgomery, Donna ^a   Onishi, Janet ^a   Losada, Maria ^a   Martin, Melissa ^a   Ebert, Timothy ^a   Tan, Charles Y ^a   Schofield, Timothy L ^a   Nagy, Eszter ^b   Meineke, Andreas ^b   Joyce, Joseph G ^a   Kurtz, Myra B ^a   Caulfield, Michael J ^a   Jansen, Kathrin U ^c   McClements, William ^a   Anderson, Annaliesa S ^a   more..

^a MERCK RESEARCH LABORATORIES   (United States)

^b INTERCELL AG   (Austria)

^c VaxGen Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMORPHOUS ALUMINUM HYDROXYPHOSPHATE SULFATE; HARA PROTEIN; IMMUNOLOGICAL ADJUVANT; IRON SURFACE DETERMINANT B; MEMBRANE PROTEIN; METICILLIN; STAPHYLOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BACTERIUM ISOLATE; COMMUNITY ACQUIRED INFECTION; CONTROLLED STUDY; DRUG EFFECT; GENETIC CONSERVATION; HOSPITAL INFECTION; IMMUNITY; IMMUNOGENICITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPRODUCIBILITY; SEPSIS; STAPHYLOCOCCUS INFECTION; SURVIVAL; VACCINATION;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CATION TRANSPORT PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MACACA MULATTA; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; SEPSIS; SEQUENCE HOMOLOGY, AMINO ACID; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE;

EID: 33645512072     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.74.4.2215-2223.2006     Document Type: Article

References (40)

1. Anderegg, T. R., H. S. Sader, T. R. Fritsche, J. E. Ross, and R. N. Jones. 2005. Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program. Int. J. Antimicrob. Agents 26:13-21.
2. 3+ siderophore transporter from Gram-positive pathogenic bacteria. Genome Biol. 3:RESEARCH0047.
3. Barrett, D. J., and E. M. Ayoub. 1986. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin. Exp. Immunol. 63:127-134.
4. Briles, D. E., C. Forman, S. Hudak, and J. L. Claflin. 1984. The effects of subclass on the ability of anti-phosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae. J. Mol. Cell. Immunol. 1:305-309.
5. Chu, R. S., T. McCool, N. S. Greenspan, J. R. Schreiber, and C. V. Harding. 2000. CpG oligodeoxynucleotides act as adjuvants for pneumococcal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infect. Immun. 68:1450-1456.
6. Dryla, A., D. Gelbmann, A. von Gabain, and E. Nagy. 2003. Identification of a novel iron regulated staphylococcal surface protein with haptoglobin-haemoglobin binding activity. Mol. Microbiol. 49:37-53.
7. Enright, M. C., N. P. Day, C. E. Davies, S. J. Peacock, and B. G. Spratt. 2000. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38:1008-1015.
8. Etz, H., D. B. Minh, T. Henics, A. Dryla, B. Winkler, C. Triska, A. P. Boyd, J. Sollner, W. Schmidt, U. von Ahsen, M. Buschle, S. R. Gill, J. Kolonay, H. Khalak, C. M. Fraser, A. von Gabain, E. Nagy, and A. Meinke. 2002. Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 99:6573-6578.
9. Fattom, A., S. Fuller, M. Propst, S. Winston, L. Muenz, D. He, R. Naso, and G. Horwith. 2004. Safety and immunogenicity of a booster dose of Staphylococcus aureus types 5 and 8 capsular polysaccharide conjugate vaccine (StaphVAX) in hemodialysis patients. Vaccine 23:656-663.
10. Hall, A. E., P. J. Domanski, P. R. Patel, J. H. Vernachio, P. J. Syribeys, E. L. Gorovits, M. A. Johnson, J. M. Ross, J. T. Hutchins, and J. M. Patti. 2003. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A. Infect. Immun. 71:6864-6870.
11. Hiramatsu, K., H. Hanaki, T. Ino, K. Yabuta, T. Oguri, and F. C. Tenover. 1997. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40:135-136.
12. Hu, D. L., K. Omoe, S. Sasaki, H. Sashinami, H. Sakuraba, Y. Yokomizo, K. Shinagawa, and A. Nakane. 2003. Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection. J. Infect. Dis. 188:743-752.
13. Jansen, K. U., M. Rosolowsky, L. D. Schultz, H. Z. Markus, J. C. Cook, J. J. Donnelly, D. Martinez, R. W. Ellis, and A. R. Shaw. 1995. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine 13:1509-1514.
14. Josefsson, E., O. Hartford, L. O'Brien, J. M. Patti, and T. Foster. 2001. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J. Infect. Dis. 184:1572-1580.
15. Kuklin, N. A., G. D. Pancari, T. W. Tobery, L. Cope, J. Jackson, C. Gill, K. Overbye, K. P. Francis, J. Yu, D. Montgomery, A. S. Anderson, W. McClements, and K. U. Jansen. 2003. Real-time monitoring of bacterial infection in vivo: development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models. Antimicrob. Agents Chemother. 47:2740-2748.
16. Lee, C. J., L. H. Lee, and C. E. Frasch. 2003. Protective immunity of pneumococcal glycoconjugates. Crit. Rev. Microbiol. 29:333-349.
17. Lee, C. J., T. R. Wang, and C. E. Frasch. 2001. Immunogenicity in mice of pneumococcal glycoconjugate vaccines using pneumococcal protein carriers. Vaccine 19:3216-3225.
18. Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med. 339:520-532.
19. Luong, T. T., and C. Y. Lee. 2002. Overproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence. Infect. Immun. 70:3389-3395.
20. Mamo, W., M. Boden, and J. I. Flock. 1994. Vaccination with Staphylococcus aureus fibrinogen binding proteins (FgBPs) reduces colonisation of S. aureus in a mouse mastitis model. FEMS Immunol. Med. Microbiol. 10:47-53.
21. Mazmanian, S. K., E. P. Skaar, A. H. Gaspar, M. Humayun, P. Gornicki, J. Jelenska, A. Joachmiak, D. M. Missiakas, and O. Schneewind. 2003. Passage of heme-iron across the envelope of Staphylococcus aureus. Science 299:906-909.
22. Mazmanian, S. K., H. Ton-That, K. Su, and O. Schneewind. 2002. An iron-regulated sortase anchors a class of surface protein during Staphylococcus aureus pathogenesis. Proc. Natl. Acad. Sci. USA 99:2293-2298.
23. Menzies, B. E., and D. S. Kernodle. 1996. Passive immunization with antiserum to a nontoxic alpha-toxin mutant from Staphylococcus aureus is protective in a murine model. Infect. Immun. 64:1839-1841.
24. Miller, D., V. Urdaneta, and S. Park. 2002. Vancomycin-resistant Staphylococcus aureus-Pennsylvania, 2002. Morb, Mortal. Wkly. Rep. 51:902.
25. Morin, C. A., and J. L. Hadler. 2001. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J. Infect. Dis. 184:1029-1034.
26. Neth, O., D. L. Jack, M. Johnson, N. J. Klein, and M. W. Turner. 2002. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J. Immunol. 169:4430-4436.
27. Nilsson, I. M., J. M. Patti, T. Bremell, M. Hook, and A. Tarkowski. 1998. Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death. J. Clin. Investig. 101:2640-2649.
28. Nilsson, I. M., M. Verdrengh, R. G. Ulrich, S. Bavari, and A. Tarkowski. 1999. Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J. Infect. Dis. 180:1370-1373.
29. O'Riordan, K., and J. C. Lee. 2004. Staphylococcus aureus capsular polysaccharides. Clin. Microbiol. Rev. 17:218-234.
30. Palavecino, E. 2004. Community-acquired methicillin-resistant Staphylococcus aureus infections. Clin. Lab. Med. 24:403-418.
31. Patti, J. M. 2004. A humanized monoclonal antibody targeting Staphylococcus aureus. Vaccine 22(Suppl. 1):S39-S43.
32. Reed, G. F., B. D. Meade, and M. C. Steinhoff. 1995. The reverse cumulative distribution plot: a graphic method for exploratory analysis of antibody data. Pediatrics 96:600-603.
33. Ryding, U., J. I. Flock, M. Flock, B. Soderquist, and B. Christensson. 1997. Expression of collagen-binding protein and types 5 and 8 capsular polysaccharide in clinical isolates of Staphylococcus aureus. J. Infect. Dis. 176:1096-1099.
34. Schennings, T., A. Heimdahl, K. Coster, and J. I. Flock. 1993. Immunization with fibronectin binding protein from Staphylococcus aureus protects against experimental endocarditis in rats. Microb. Pathog. 15:227-236.
35. Shinefield, H., S. Black, A. Fattom, G. Horwith, S. Rasgon, J. Ordonez, H. Yeoh, D. Law, J. B. Robbins, R. Schneerson, L. Muenz, S. Fuller, J. Johnson, B. Fireman, H. Alcorn, and R. Naso. 2002. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N. Engl. J. Med. 346:491-496.
36. Sievert, D. M., M. L. Boulton, G. Stoltman, D. Johnson, M. G. Stobierski, F. P. Downes, P. A. Somsel, J. T. Rudrik, W. Brown, W. Hafeez, T. Lundstrom, E. Flanagan, R. Johnson, J. Mitchell, and S. Chang. 2002. Staphylococcus aureus resistant to vancomycin-United States, 2002. Morb. Mortal. Wkly. Rep. 51:565-567.
37. Skaar, E. P., and O. Schneewind. 2004. Iron-regulated surface determinants (Isd) of Staphylococcus aureus: stealing iron from heme. Microbes Infect. 6:390-397.
38. Solomon, S., T. Horan, M. Andrus, J. Edwards, G. Emori, S. Fridkin, G. Peavy, J. Tolson, S. Upadhyayula, and B. Yi. 2002. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 to June 2002, issued August 2002. Am. J. Infect. Control. 30:458-475.
39. Solomon, S., T. Horan, M. Andrus, J. Edwards, S. Fridkin, J. Koganti, G. Peavy, and J. Tolson. 2003. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2003, issued August 2003. Am. J. Infect. Control. 31:481-498.
40. Underhill, D. M., and A. Ozinsky. 2002. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 20:825-852.